---
figid: PMC8564965__13046_2021_2156_Fig2_HTML
figtitle: 'Fibroblast growth factor receptor fusions in cancer: opportunities and
  challenges'
organisms:
- Homo sapiens
- Mus musculus
- NA
pmcid: PMC8564965
filename: 13046_2021_2156_Fig2_HTML.jpg
figlink: /pmc/articles/PMC8564965/figure/Fig2/
number: F2
caption: FGFR signaling in cancers. FGF, HSPG, and FGFR form 2:2:2 ternary complex,
  followed by receptor dimerization and kinase transphosphorylation. FGFR downstream
  adaptor protein FRS2 interacts with SHP2 and GRB2 complex, leading to subsequent
  activation of PI3K-AKT and RAS-MEK-ERK signaling pathways. Another FGFR substrate,
  PLC-g, binds to phosphotyrosine and hydrolyzes PIP2 to generate IP3 and DAG, which
  in turn activate PKC and MAPK pathway, resulting in cell migration, proliferation,
  and differentiation. Depending on the cellular context, FGFRs have the capability
  to activate the JAK-STAT3 signalling pathway. Aberrant FGFR signaling may be induced
  by (i) increased expression of FGFs (ligand-dependent), or (ii) FGFR alteration,
  including mutation, amplification or translocation (ligand-independent)
papertitle: 'Fibroblast growth factor receptor fusions in cancer: opportunities and
  challenges.'
reftext: Lingfeng Chen, et al. J Exp Clin Cancer Res. 2021;40:345.
year: '2021'
doi: 10.1186/s13046-021-02156-6
journal_title: 'Journal of Experimental & Clinical Cancer Research : CR'
journal_nlm_ta: J Exp Clin Cancer Res
publisher_name: BioMed Central
keywords: Fibroblast growth factor receptors | Fusion proteins | Chromosomal translocation
  | Cancer | Inhibitors
automl_pathway: 0.9160094
figid_alias: PMC8564965__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8564965__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8564965__13046_2021_2156_Fig2_HTML.html
  '@type': Dataset
  description: FGFR signaling in cancers. FGF, HSPG, and FGFR form 2:2:2 ternary complex,
    followed by receptor dimerization and kinase transphosphorylation. FGFR downstream
    adaptor protein FRS2 interacts with SHP2 and GRB2 complex, leading to subsequent
    activation of PI3K-AKT and RAS-MEK-ERK signaling pathways. Another FGFR substrate,
    PLC-g, binds to phosphotyrosine and hydrolyzes PIP2 to generate IP3 and DAG, which
    in turn activate PKC and MAPK pathway, resulting in cell migration, proliferation,
    and differentiation. Depending on the cellular context, FGFRs have the capability
    to activate the JAK-STAT3 signalling pathway. Aberrant FGFR signaling may be induced
    by (i) increased expression of FGFs (ligand-dependent), or (ii) FGFR alteration,
    including mutation, amplification or translocation (ligand-independent)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Stat3
  - Frs2
  - Ptpn11
  - Gab1
  - Pik3r1
  - Akt1
  - ras
  - Hras
  - Kras
  - Rem1
  - Ephb2
  - Mapk1
  - Zhx2
  - Mdk
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - STAT3
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - FRS2
  - PTPN11
  - GAB1
  - PIGU
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - XYLT2
  - SOS1
  - SOS2
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - EPHB2
  - MAPK1
  - MAPK3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
---
